Alexion Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 106   

Articles published

ALXN 176.04 +0.41 (0.23%)
price chart
Alexion Pharmaceuticals Inc. (ALXN) Falls 4.26% for March 25
One of the S&P 500's big losers for Wednesday March 25 was Alexion Pharmaceuticals Inc. (ALXN). The company's stock fell 4.26% to $175.63 on volume of 1.39 million shares.
Stocks with High ROA: Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN ...  Wall Street Observer
ALXN Makes Notable Cross Below Critical Moving Average  Nasdaq
Bull of the Day: Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) $189.09 +0.48%
Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) shares surged +0.48% during yesterday's session, closing at $189.09. The share price was trading in a wide range between the psychological level of $170.00 and the key resistance level of $188.20.
Alexion Pharmaceuticals Earns Buy Rating from BTIG Research (ALXN)  The Legacy
Investors Buy Shares of Alexion Pharmaceuticals on Weakness After Insider ...  sleekmoney
Alexion Pharmaceuticals, Inc. Short Interest Disclosure
The short interest in Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) has increased from 3,065,921 on February 13,2015 to 3,169,834 on February 27,2015.
Analyst: Alexion Pharmaceuticals Pipeline Is Undervalued  Benzinga
First Call Rating Update on Alexion Pharmaceuticals, Inc.  Wall Street Pulse
Alexion Pharmaceuticals Inc. (ALXN) Pops 3.15% for March 17
One of the S&P 500's big winners for Tuesday March 17 was Alexion Pharmaceuticals Inc. ($ALXN) as the company's stock climbed 3.15% to $184.12 on volume of 1.57 million shares.
Commit To Buy Alexion Pharmaceuticals At $145, Earn 11% Using Options  Nasdaq
Can This Biotech Stock Go from Good to Great?  Motley Fool
Stock Insights on Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
Article: Several analysts have recently weighed on Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN), issuing notes to investors.
Insider Selling: Leonard Bell Sells 15952 Shares of Alexion Pharmaceuticals ...  sleekmoney
Insider Selling: Alexion Pharmaceuticals CEO Sells $3000092.64 in Stock (ALXN)
Alexion Pharmaceuticals has a 1-year low of $136.37 and a 1-year high of $203.30. The stock has a 50-day moving average of $181.
Analyst Rating Update on Alexion Pharmaceuticals, Inc.
Alexion Pharmaceuticals (NASDAQ:ALXN) has received a short term rating of hold from research analysts at Zacks with a rank of 3. The company has been rated an average of 1.28 by 16 Wall Street Analysts. 13 analysts have added the counter in their list ...
Traders Buy Alexion Pharmaceuticals on Weakness (ALXN)  Intercooler
Investors Buy Alexion Pharmaceuticals on Weakness on Insider Selling (ALXN)
Alexion Pharmaceuticals logo Investors purchased shares of Alexion Pharmaceuticals (NASDAQ:ALXN) on weakness during trading hours on Friday after an insider sold shares in the company, American Banking and Market News reports. $270.85 million ...
Coverage of Biotech Equities -- MannKind, Novavax, Curis, Pharmacyclics, and ...
Alexion Pharmaceuticals Inc.'s stock finished Monday's session 1.79% higher at $184.91. A total of 0.90 million shares were traded, which was below its three months average volume of 1.26 million shares.
Alexion Pharmaceuticals Takes Over #13 Spot From Tyson Foods
In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Alexion Pharmaceuticals Inc. (Symbol: ALXN) has taken over the #13 spot from Tyson Foods, Inc. (Symbol: TSN), according to ETF Channel .
Stocks with High ROA - Visa Inc (NYSE:V), SouFun Holdings Ltd (NYSE:SFUN ...  Wall Street Observer